Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, indicating an updated version of the page content. This is a maintenance update and does not modify study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-26T23:16:24.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The Study Details page now indicates recruitment is closed by displaying 'No longer looking for participants', and adds new help/join sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a heading formatting change for Intervention/Treatment and a Revision: v3.6.0 update.
    Difference
    0.1%
    Check dated 2026-06-12T14:25:33.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The locations list updates the Kharkiv entry to Kharkiv Oblast, adding Kharkiv, Kharkiv Oblast, Ukraine, 61000, and the revision tag advances to v3.5.5.
    Difference
    0.0%
    Check dated 2026-06-05T10:23:19.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer build of the page's documentation or interface. This reflects an incremental deployment change to the page.
    Difference
    0.0%
    Check dated 2026-05-15T05:37:48.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Two new sites were added: Malmö, Skåne County, Sweden, 205 02 and Taoyuan, Taiwan, 333; two existing entries were removed/renamed: Malmo, Skåne County, Sweden, 205 02 and Taoyuan District, Taiwan, 333. This update reflects the updated geographic identifiers for trial locations.
    Difference
    0.0%
    Check dated 2026-05-08T10:31:26.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Results have been posted for the study, including primary and secondary outcomes (e.g., RFS and OS definitions and time frames), adverse events, and quality-of-life measures. The update also references the Study Protocol and Statistical Analysis Plan and lists the results reporting dates.
    Difference
    1.0%
    Check dated 2026-05-01T08:21:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.